CRISPR-Cas9: A revolution in genome editing in rheumatic diseases.
Inserm, U1183, IRMB, université de Montpellier, clinical department for osteoarticular diseases, CHRU de Montpellier, 80, rue Augustin-Fliche, 34295 Montpellier, France.
Isabelle
I
Duroux-Richard
Museum national d'histoire naturelle, structure et instabilité des génomes, Inserm U 1154 - CNRS UMR 7196, 43, rue Cuvier, 75231 Paris, France.
Carine
C
Giovannangeli
Inserm, U1183, IRMB, université de Montpellier, clinical department for osteoarticular diseases, CHRU de Montpellier, 80, rue Augustin-Fliche, 34295 Montpellier, France. Electronic address: florence.apparailly@inserm.fr.
Florence
F
Apparailly
D000818:Animals; D064113:CRISPR-Cas Systems / Q000235:genetics*; D064112:Clustered Regularly Interspaced Short Palindromic Repeats / Q000235:genetics*; D000072669:Gene Editing; D018390:Gene Targeting / Q000379:methods*; D005818:Genetic Engineering / Q000379:methods; D015316:Genetic Therapy / Q000379:methods; D016678:Genome; D023281:Genomics / Q000379:methods*; D006801:Humans; D017393:RNA Editing; D012216:Rheumatic Diseases / Q000235:genetics* / Q000628:therapy; D012680:Sensitivity and Specificity
CRISPR-Cas; Genome editing; Rheumatism